| Name | Title | Contact Details |
|---|
Full Swing is the worldwide leader in cutting-edge indoor golf simulation technology. Full Swing simulators are in the homes of top Tour Pros including Tiger Woods, Jordan Spieth, Jason Day, Jim Furyk, Padraig Harrington, Smylie Kaufman, and many more. Our patented dual tracking technology delivers superior ball tracking data and makes Full Swing the only simulator that actually measures ball flight indoors. With over 30 years of experience, Full Swing provides the most accurate and realistic golf experience you can find. From practice to instruction, to entertainment, this is the world-class experience youve been looking for. For further information, please visit www.fullswinggolf.com.
Blue Giant Equipment Corporation is a prominent global manufacturer and distributor of loading dock systems and material handling equipment, headquartered in Toronto, Ontario, Canada. Founded in 1963 by Kurt Larsen, the company has celebrated over 60 years of innovation in the industry. Blue Giant began with mechanical dock levelers and hand pallet trucks, later expanding its offerings to include intelligent dock controls and air-powered loading dock equipment. The company provides a wide range of products, including loading dock systems, material handling equipment, HVLS fans, and ergonomic lift assist solutions. Their innovative Blue Genius Connect control panel enhances the management of loading dock operations. Blue Giant has received multiple awards for its products, including recognition in the Professional Door Dealer magazines "Best of Business Dealers Choice Poll" and a Bronze Award from Plant Engineering magazine. With a commitment to growth, Blue Giant relocated its headquarters in 2017 to a larger facility in Mississauga, Ontario, reflecting its dedication to expanding its capabilities in the material handling sector.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
When it comes to the world of automotive components, JVIS has continued to be the supplier of choice for leading global brands. Why? Were fast. Were flexible. Were everywhere. With our extensive art-to-part capabilities, we can do whatever it takes to help our customers get the solution they need. And facilities around the world and an international network of dedicated partners — we can provide global services with localized support you cant get from other suppliers. Thats great news for both your production line and bottom line. Whether you need a sleek new exterior part or a complete interior solution that creates a more comfortable ride, our team of experts can quickly design, produce and deliver exactly what you need.
For information on open opportunities, review our job posting or email HR@AspirePartnersUSA.com